The biopharma world's manufacturing weekly

Endpoints Manufacturing

Manufacturing channel feed

Fu­ji­film makes $200M man­u­fac­tur­ing in­vest­ment while No­var­tis pours $80M+ in­to Chi­na fa­cil­i­ty

9 hours ago
Pharma

WuXi Bi­o­log­ics’ stock slides 24% as man­u­fac­tur­ing busi­ness slows amid biotech down­turn

17 hours ago

FDA ships Form 483 to gener­ic drug gi­ant Dr. Red­dy’s due to equip­ment is­sues, oth­er ob­ser­va­tions

4 days ago
Pharma
FDA+

2024 VC fore­cast: Clin­i­cal-stage CD­MOs like­ly to have uptick in de­mand but spe­cial­iza­tion crit­i­cal

4 days ago

Charles Riv­er works on rare dis­ease gene ther­a­py; Emer­gent gets $75M for an­thrax vac­cine; Eu­roAPI hires new COO 

4 days ago

Cell man­u­fac­tur­ing com­pa­ny rais­es $19M Se­ries A to in­crease ca­pac­i­ty, staff num­bers 

4 days ago
Financing

In­tas Phar­ma­ceu­ti­cal­s' In­di­an fa­cil­i­ty hit with FDA warn­ing let­ter, placed on im­port alert

5 days ago
FDA+

Am­gen teams up with Ama­zon on AI plat­form to en­hance new Ohio man­u­fac­tur­ing site

5 days ago
AI

Big Phar­ma unites to help boost re­new­able en­er­gy for sup­ply chains in Chi­na and In­dia

5 days ago

RoslinCT to com­mer­cial­ly man­u­fac­ture CRISPR-edit­ed ther­a­py Cas­gevy af­ter col­lab ex­ten­sion with Ver­tex, CRISPR

6 days ago
Cell/Gene Tx

US gov­ern­ment turns to more do­mes­tic phar­ma man­u­fac­tur­ing to im­prove sup­ply chain re­silience 

Last week
Pharma

No­vo Nordisk in­vests $2.4B in French fa­cil­i­ty to ad­dress boom­ing GLP-1 de­mand

Last week

Re­ci­pharm to change CEOs, spin out in­haler busi­ness

Last week

FDA warns Cipla's al­buterol in­haler plant af­ter thou­sands of com­plaints

Last week
R&D
FDA+

GSK boosts low-car­bon in­haler de­vel­op­ment with PhI­II tri­als, in­vest­ment in French man­u­fac­tur­ing fa­cil­i­ty 

Last week
Pharma

Bay­er re­calls one lot of sol­id tu­mor drug Vi­t­rakvi af­ter find­ing mi­cro­bial con­t­a­m­i­na­tion

2 weeks ago
Pharma

CD­MOs in­ves­ti­gate how to sup­port GLP-1 man­u­fac­tur­ing, phar­ma con­sid­ers sup­ply chain di­ver­si­ty: #Jef­feries23

3 weeks ago

Lil­ly in­vests $2.5B in new Ger­man site to boost tirzepatide sup­ply, $100M for lo­cal biotechs

3 weeks ago
R&D

As­traZeneca sub­sidiary to sell its Ban­ga­lore site, to hunt for ex­ter­nal man­u­fac­tur­er 

3 weeks ago

San­doz opens two new fa­cil­i­ties; Gates Foun­da­tion funds nee­dle-free vac­cines; No­var­tis ex­pands Japan­ese site

3 weeks ago

Ozem­pic short­ages have Eu­ro­pean coun­tries ex­plor­ing bans on use of pop­u­lar drug for weight loss

3 weeks ago
Pharma

Is the worst over? Catal­ent touts GLP-1 and gene ther­a­py busi­ness as it sticks to fi­nan­cial guid­ance

3 weeks ago

Ex­clu­sive: NTx rais­es $47.5M Se­ries B to com­mer­cial­ize pro­tein, mR­NA man­u­fac­tur­ing plat­forms 

3 weeks ago
Financing

Aji­nomo­to to buy gene ther­a­py CD­MO Forge Bi­o­log­ics in $620M all-cash deal

3 weeks ago
Deals
1234 Next page Last page
A service from the Financial Times